The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.

When it comes to clean eating, it means that the food should be free of chemcials and any sort of additive. But, sadly, when ...

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...

Biocon Biologics' own Insulin Aspart drug product for the US is currently under review by the US Food and Drug Administration ...

The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...

Biocon Biologics partners with Civica to enhance access to Insulin Aspart in the US, no tech transfer involved.

A new study has found that the diabetes drug tirzepatide helps people lower their blood sugar and lose weight more quickly ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

The National Agency for Food and Drug Administration and Control has raised the alarm over the illegal circulation and marketing of a substandard and falsified medical product, the Knowit Insulin ...

Biocon Biologics has partnered with Civica to improve access to and affordability of insulin aspart in the U.S. Biocon will ...

California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin ...